XML 44 R30.htm IDEA: XBRL DOCUMENT v3.22.0.1
STOCK COMPENSATION PLAN (Tables)
12 Months Ended
Dec. 31, 2021
Compensation Related Costs [Abstract]  
SCHEDULE OF FAIR VALUE OF OPTION GRANT OF WEIGHTED-AVERAGE ASSUMPTIONS

The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions used for grants in the following years:

 

   2021   2020   2019 
             
Dividend yield   4.66%   5.33%   5.13%
Expected volatility   24.59%   24.57%   24.04%
Risk-free interest rate   1.44%   0.89%   2.50%
Expected lives   10    10    10 
Estimated forfeitures   -0-    -0-    -0- 
SCHEDULE OF STOCK OPTION PLANS AND CHANGES IN STOCK OPTIONS

A summary of the status of the stock options outstanding under the Company’s stock compensation plans as of December 31, 2021, 2020 and 2019 and changes during the years then ended are as follows (in thousands):

 

   2021   2020   2019 
       Weighted-       Weighted-       Weighted- 
       Average       Average       Average 
       Exercise       Exercise       Exercise 
   Shares   Price   Shares   Price   Shares   Price 
                         
Outstanding at
beginning of year
   3,266   $12.03    2,637   $12.05    2,253   $12.09 
Granted   768    21.90    715    9.84    644    13.67 
Exercised   (710)   12.11    (63)   10.55    (240)   10.84 
Forfeited   -0-    19.36    (11)   11.65    (20)   13.50 
Expired   -0-    -0-    (12)   11.29    -0-    -0- 
Outstanding at end of
year
   3,324    14.25    3,266    12.03    2,637    12.05 
Options exercisable at
end of year
   2,556         2,556         1,196      
Weighted average fair
value of options
granted during the year
       $2.77        $0.96        $1.72 
SUMMARY OF STOCK OPTIONS OUTSTANDING

The following is a summary of stock options outstanding as of December 31, 2021 (in thousands):

 

 

Date of Grant

   Number of Employees   Number of Shares  

Option Price

   Expiration Date
                 
06/11/14    4    136    9.85   06/11/22
06/24/15    5    195    9.82   06/24/23
04/05/16    8    237    9.77   04/05/24
01/19/17    2    60    14.25   01/19/27
04/04/17    21    422    15.04   04/04/27
04/02/18    17    301    13.09   04/02/28
07/09/18    4    40    15.75   07/09/28
12/10/18    1    25    12.94   12/10/28
01/02/19    2    60    11.42   01/02/29
04/02/19    19    419    13.90   04/02/29
01/17/20    1    10    16.37   01/17/30
03/25/20    39    637    9.70   03/25/30
05/20/20    2    14    11.80   05/20/30
03/18/21    41    159*   19.36   03/18/31
07/14/21    46    609*   22.57   07/14/31
                    
          3,324         

 

* Unexercisable
SCHEDULE OF PERFORMANCE-BASED VESTING CRITERIA

 

Vesting Date   Performance Goal to be Met (1)  

Percent of Shares Vested

June 30, 2023  

Growth in cumulative Normalized Funds from Operations (“Normalized FFO”) over the past 3 years is 2% or greater

 

  100%
June 30, 2023  

Growth in cumulative Normalized FFO over the past 3 years is 5% or greater

 

  Bonus of 50% of the Restricted Stock (total of 150%)
June 30, 2023  

Growth in cumulative Normalized FFO over the past 3 years is 20% or greater

 

  Bonus of 100% of the Restricted Stock (total of 200%)

 

 

(1) Growth in cumulative Normalized FFO is measured as the trailing 12-month Normalized FFO per share at June 30, 2023 divided by the trailing 12-month Normalized FFO per share at June 30, 2020, which amount is $0.64/share at June 30, 2020.
SCHEDULE OF NONVESTED RESTRICTED STOCK AWARDS

A summary of the status of the Company’s non-vested restricted stock awards as of December 31, 2021, 2020 and 2019, and changes during the year ended December 31, 2021, 2020 and 2019 are presented below (in thousands):

   2021   2020   2019 
       Weighted-       Weighted-       Weighted- 
       Average       Average       Average 
       Grant Date       Grant Date       Grant Date 
   Shares   Fair Value   Shares   Fair Value   Shares   Fair Value 
                         
Non-vested at
beginning of year
   212   $13.69    238   $13.33    161   $12.44 
Granted   280    16.51    35    14.75    118    11.12 
Dividend Reinvested Shares   15    21.68    11    12.91    11    13.51 
Vested   (73)   8.48    (72)   12.87    (52)   5.69 
 Non-vested at end of year   434   $16.66    212   $13.69    238   $13.33